Literature DB >> 10556093

Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF.

H Zhang1, L Wang, S Kao, I P Whitehead, M J Hart, B Liu, K Duus, K Burridge, C J Der, L Su.   

Abstract

The long cytoplasmic tail of the human immunodeficiency virus (HIV)-1 transmembrane protein gp41 (gp41C) is implicated in the replication and cytopathicity of HIV-1 [1]. Little is known about the specific functions of gp41C, however. HIV-1 or simian immunodeficiency virus (SIV) mutants with defective gp41C have cell-type- or species-dependent phenotypes [2] [3] [4] [5] [6]. Thus, host factors are implicated in mediating the functions of gp41C. We report here that gp41C interacted with the carboxy-terminal regulatory domain of p115-RhoGEF [7], a specific guanine nucleotide exchange factor (GEF) and activator of the RhoA GTPase, which regulates actin stress fiber formation, activation of serum response factor (SRF) and cell proliferation [8] [9]. We demonstrate that gp41C inhibited p115-mediated actin stress fiber formation and activation of SRF. An amphipathic helix region with a leucine-zipper motif in gp41C is involved in its interaction with p115. Mutations in gp41C leading to loss of interaction with p115 impaired HIV-1 replication in human T cells. These findings suggest that an important function of gp41C is to modulate the activity of p115-RhoGEF and they thus reveal a new potential anti-HIV-1 target.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556093      PMCID: PMC4513661          DOI: 10.1016/s0960-9822(99)80511-9

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  21 in total

1.  A leucine zipper-like sequence from the cytoplasmic tail of the HIV-1 envelope glycoprotein binds and perturbs lipid bilayers.

Authors:  Y Kliger; Y Shai
Journal:  Biochemistry       Date:  1997-04-29       Impact factor: 3.162

Review 2.  Retrovirus envelope glycoproteins.

Authors:  E Hunter; R Swanstrom
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors.

Authors:  A J Ridley; A Hall
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

4.  Interruption of T-cell signal transduction by lentivirus lytic peptides from HIV-1 transmembrane protein.

Authors:  T P Beary; S B Tencza; T A Mietzner; R C Montelaro
Journal:  J Pept Res       Date:  1998-01

Review 5.  Dbl family proteins.

Authors:  I P Whitehead; S Campbell; K L Rossman; C J Der
Journal:  Biochim Biophys Acta       Date:  1997-02-22

Review 6.  Rho GTPases and signaling networks.

Authors:  L Van Aelst; C D'Souza-Schorey
Journal:  Genes Dev       Date:  1997-09-15       Impact factor: 11.361

7.  Rho is a negative regulator of human monocyte spreading.

Authors:  M Aepfelbacher; M Essler; E Huber; A Czech; P C Weber
Journal:  J Immunol       Date:  1996-12-01       Impact factor: 5.422

8.  Calmodulin-binding function of LLP segments from the HIV type 1 transmembrane protein is conserved among natural sequence variants.

Authors:  S B Tencza; T A Mietzner; R C Montelaro
Journal:  AIDS Res Hum Retroviruses       Date:  1997-02-10       Impact factor: 2.205

9.  Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity.

Authors:  J W Dubay; S J Roberts; B H Hahn; E Hunter
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

10.  Significance of premature stop codons in env of simian immunodeficiency virus.

Authors:  T Kodama; D P Wooley; Y M Naidu; H W Kestler; M D Daniel; Y Li; R C Desrosiers
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

View more
  32 in total

1.  Modulation of HIV-1 replication by a novel RhoA effector activity.

Authors:  L Wang; H Zhang; P A Solski; M J Hart; C J Der; L Su
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

2.  A leucine zipper motif in the cytoplasmic domain of gp41 is required for HIV-1 replication and pathogenesis in vivo.

Authors:  S M Kao; E D Miller; L Su
Journal:  Virology       Date:  2001-10-25       Impact factor: 3.616

3.  RhoA biological activity is dependent on prenylation but independent of specific isoprenoid modification.

Authors:  Patricia A Solski; Whitney Helms; Patricia J Keely; Lishan Su; Channing J Der
Journal:  Cell Growth Differ       Date:  2002-08

4.  Modulation of Env content in virions of simian immunodeficiency virus: correlation with cell surface expression and virion infectivity.

Authors:  Eloísa Yuste; Jacqueline D Reeves; Robert W Doms; Ronald C Desrosiers
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

5.  Citron kinase, a RhoA effector, enhances HIV-1 virion production by modulating exocytosis.

Authors:  Rebecca J Loomis; Derek A Holmes; Andrew Elms; Patricia A Solski; Channing J Der; Lishan Su
Journal:  Traffic       Date:  2006-12       Impact factor: 6.215

6.  Modulation of NFAT-dependent gene expression by the RhoA signaling pathway in T cells.

Authors:  Whitney S Helms; Jerry L Jeffrey; Derek A Holmes; Michael B Townsend; Neil A Clipstone; Lishan Su
Journal:  J Leukoc Biol       Date:  2007-05-14       Impact factor: 4.962

Review 7.  Regulation and physiological functions of G12/13-mediated signaling pathways.

Authors:  Nobuchika Suzuki; Nicole Hajicek; Tohru Kozasa
Journal:  Neurosignals       Date:  2009-02-12

8.  Ezrin is a component of the HIV-1 virological presynapse and contributes to the inhibition of cell-cell fusion.

Authors:  Nathan H Roy; Marie Lambelé; Jany Chan; Menelaos Symeonides; Markus Thali
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

9.  Characterization of G alpha 13-dependent plasma membrane recruitment of p115RhoGEF.

Authors:  Raja Bhattacharyya; Philip B Wedegaertner
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

10.  Identification of the cellular prohibitin 1/prohibitin 2 heterodimer as an interaction partner of the C-terminal cytoplasmic domain of the HIV-1 glycoprotein.

Authors:  Vanessa Emerson; Denise Holtkotte; Tanya Pfeiffer; I-Hsuan Wang; Martina Schnölzer; Tore Kempf; Valerie Bosch
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.